(Q44386224)

2 December 2017

p53 and WAF1 polymorphisms in Jewish-Israeli women with epithelial ovarian cancer and its association with BRCA mutations (English)

1 reference

2 December 2017

0 references

1 reference

3

Chetrit A

1 reference

2 December 2017

Yair D

1

1 reference

2 December 2017

Ben Baruch G

2

1 reference

2 December 2017

Friedman T

4

1 reference

2 December 2017

Hirsh Yechezkel G

5

1 reference

2 December 2017

Gotlieb WH

6

1 reference

2 December 2017

Fishman A

7

1 reference

2 December 2017

Beller U

8

1 reference

2 December 2017

Bar-Am A

9

1 reference

2 December 2017

Friedman E

10

1 reference

2 December 2017

1 July 2000

1 reference

BJOG: an International Journal of Obstetrics and Gynaecology

2 December 2017

1 reference

2 December 2017

107

1 reference

2 December 2017

849-854

1 reference

2 December 2017

7

1 reference

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

2 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

BRCA1 regulates p53-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11082.X

10.1111/J.1471-0528.2000.TB11082.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference